Arcus Biosciences Stock Price on March 20, 2024
| RCUS Stock | USD 17.55 0.44 2.57% |
Below is the normalized historical share price chart for Arcus Biosciences extending back to March 15, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcus Biosciences stands at 17.55, as last reported on the 16th of May 2024, with the highest price reaching 18.07 and the lowest price hitting 17.26 during the day.
If you're considering investing in Arcus Stock, it is important to understand the factors that can impact its price. We consider Arcus Biosciences somewhat reliable. Arcus Biosciences secures Sharpe Ratio (or Efficiency) of 0.0367, which signifies that the company had a 0.0367% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Arcus Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Arcus Biosciences' risk adjusted performance of 0.0388, and Mean Deviation of 2.95 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%.
At this time, Arcus Biosciences' Common Stock is comparatively stable compared to the past year. Capital Stock is likely to gain to about 1.4 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 57.8 M in 2024. . At this time, Arcus Biosciences' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.39 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (4.37). Arcus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of March 2018 | 200 Day MA 17.2426 | 50 Day MA 16.8012 | Beta 0.908 |
Arcus |
Sharpe Ratio = 0.0367
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RCUS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.22 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Arcus Biosciences is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcus Biosciences by adding it to a well-diversified portfolio.
Price Book 3.2609 | Enterprise Value Ebitda (2.61) | Price Sales 12.8764 | Shares Float 54.5 M | Wall Street Target Price 38.7 |
Related Headline
Blueprint Medicines Headline on 20th of March 2024
Disposition of 10000 shares by Jeffrey Albers of Blueprint M... by Jeffrey Albers
Filed transaction by Blueprint Medicines Corp Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Arcus Biosciences Valuation on March 20, 2024
It is possible to determine the worth of Arcus Biosciences on a given historical date. On March 20, 2024 Arcus was worth 17.19 at the beginning of the trading date compared to the closed value of 17.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcus Biosciences stock. Still, in general, we apply an absolute valuation method to find Arcus Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcus Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcus Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 17.16 | 17.66 | 17.03 | 17.30 | 568,792 | |
03/20/2024 | 17.19 | 17.67 | 17.01 | 17.49 | 485,700 |
| 17.48 | 18.08 | 17.22 | 17.24 | 620,114 |
| Backtest Arcus Biosciences | | | Arcus Biosciences History | | | Arcus Biosciences Valuation | Previous | Next |
Arcus Biosciences Trading Date Momentum on March 20, 2024
| On March 21 2024 Arcus Biosciences was traded for 17.24 at the closing time. The top price for the day was 18.08 and the lowest listed price was 17.22 . The trading volume for the day was 620.1 K. The trading history from March 21, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.43% . The overall trading delta against the current closing price is 7.38% . |
Arcus Biosciences Fundamentals Correlations and Trends
By evaluating Arcus Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arcus Biosciences Stock history
Arcus Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcus Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcus Biosciences stock prices may prove useful in developing a viable investing in Arcus Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 74 M | 57.8 M | |
| Net Loss | -240.3 M | -228.3 M |
Arcus Biosciences Quarterly Net Working Capital |
|
Arcus Biosciences Stock Technical Analysis
Arcus Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arcus Biosciences Period Price Range
Low | March 20, 2024
| High |
17.19 | 17.49 |
Arcus Biosciences May 16, 2024 Market Strength
Market strength indicators help investors to evaluate how Arcus Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcus Biosciences shares will generate the highest return on investment. By undertsting and applying Arcus Biosciences stock market strength indicators, traders can identify Arcus Biosciences entry and exit signals to maximize returns
Arcus Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcus Biosciences' price direction in advance. Along with the technical and fundamental analysis of Arcus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0388 | |||
| Jensen Alpha | 0.2108 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0313 | |||
| Treynor Ratio | (1.11) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcus Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Arcus Stock analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Arcus Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcus Biosciences. If investors know Arcus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcus Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.11) | Revenue Per Share 3.066 | Quarterly Revenue Growth 4.8 | Return On Assets (0.12) | Return On Equity (0.35) |
The market value of Arcus Biosciences is measured differently than its book value, which is the value of Arcus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcus Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcus Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcus Biosciences' market value can be influenced by many factors that don't directly affect Arcus Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcus Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcus Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcus Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.